1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow ABT-767: new trials by email Literature Review of ABT-767 trials Research Report on ABT-767
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer ABT-767 - Fallopian Tube, Primary Peritoneal Cancer | Phase 1 | Completed | AbbVie (prior sponsor, Abbott) | 93 | 2011-05-06 | 2018-01-02 |
Fanconi Anemia, Complementation Group D1 (1)
AbbVie (prior sponsor, Abbott) (1)
Netherlands (1)